CSO

Accushield Launches #ProjectLoveMeter to Attack Senior Loneliness and Isolation

Retrieved on: 
Tuesday, February 13, 2024

ATLANTA, Feb. 13, 2024 /PRNewswire/ -- Accushield, the leader in visitor management for senior living and skilled nursing, is excited to announce the official launch of #ProjectLoveMeter.

Key Points: 
  • ATLANTA, Feb. 13, 2024 /PRNewswire/ -- Accushield, the leader in visitor management for senior living and skilled nursing, is excited to announce the official launch of #ProjectLoveMeter.
  • Unfortunately, loneliness is not a new phenomenon in senior living and skilled nursing communities.
  • Here's how Accushield's #ProjectLoveMeter flips the script on the response to senior loneliness and isolation.
  • Charles Mann, Founder and CSO at Accushield, sums it up as follows, "Our senior living and skilled nursing partners do an amazing job of caring for their residents.

New Culture Announces Self-GRAS for Animal-free Casein, World's First Cleared for Commercial Sale

Retrieved on: 
Tuesday, February 13, 2024

SAN LEANDRO, Calif., Feb. 13, 2024 /PRNewswire/ -- The world's first casein protein made without any animal inputs has been determined safe for consumption. New Culture, the animal-free dairy company, has self-affirmed that its animal-free casein is Generally Recognized as Safe ("GRAS") following a recent review by an independent panel of qualified scientific and toxicology experts. The company's self-GRAS determination means its casein can be sold, used, and consumed in the U.S. like any other food ingredient.

Key Points: 
  • New Culture , the animal-free dairy company, has self-affirmed that its animal-free casein is Generally Recognized as Safe ("GRAS") following a recent review by an independent panel of qualified scientific and toxicology experts.
  • The company's self-GRAS determination means its casein can be sold, used, and consumed in the U.S. like any other food ingredient.
  • This proven manufacturing process, precision fermentation, has been used for decades to make food ingredients and pharmaceuticals cost effectively, sustainably and animal-free.
  • New Culture intends to notify FDA of its self-GRAS determination in the near future.

RSA Conference Releases Initial 2024 Keynote Speaker Lineup

Retrieved on: 
Tuesday, February 13, 2024

SAN FRANCISCO, Feb. 13, 2024 /PRNewswire/ -- RSA Conference™, the world's leading cybersecurity conferences and expositions, today announced its initial lineup of keynote speakers for its upcoming Conference, taking place at the Moscone Center in San Francisco from May 6-9, 2024.

Key Points: 
  • SAN FRANCISCO, Feb. 13, 2024 /PRNewswire/ -- RSA Conference™, the world's leading cybersecurity conferences and expositions, today announced its initial lineup of keynote speakers for its upcoming Conference, taking place at the Moscone Center in San Francisco from May 6-9, 2024.
  • Dozens of prominent cybersecurity experts and innovators are slated to speak at RSA Conference 2024 from May 6-9.
  • "The Art of Possible is the theme for Conference this year and that's embodied throughout the lineup for our keynote program in 2024," said Linda Gray Martin, Senior Vice President, RSA Conference.
  • White, Former Commander, U.S. Fleet Cyber Command and U.S. Tenth Fleet
    For more information about the keynote program and to stay up to date with what's happening at RSA Conference 2024, please visit our website at https://www.rsaconference.com/usa .

SaliCrop's Novel Seed Enhancement Tech Makes Deserts Bloom

Retrieved on: 
Tuesday, February 13, 2024

KFAR VITKIN, Israel, Feb. 13, 2024 /PRNewswire/ -- Extreme weather events—heatwaves, droughts, extreme cold snaps—pose significant threats to agriculture, contributing to the phenomenon of desertification. Globally, fertile lands are increasingly being degraded, losing the ability to sustain life and grow food. AgriTech start-up SaliCrop, Ltd., has pioneered a breakthrough seed treatment to transform arid terrain into flourishing landscapes to growing food.

Key Points: 
  • AgriTech start-up SaliCrop, Ltd., has pioneered a breakthrough seed treatment to transform arid terrain into flourishing landscapes to growing food.
  • SaliCrop's proprietary seed enhancement technology is the brainchild of Ṛcā Godbole, Ph.D., co-founder and CSO of SaliCrop.
  • SaliCrop's has developed  hundreds of seed enhancement protocols designed to improve plant resilience to the impacts of climate change by intentionally exposing the seeds to controlled abiotic stressors.
  • "Our climate-smart seed enhancement technology has empowered tomatoes to better withstand extreme climate events," adds Devir.

SaliCrop's Novel Seed Enhancement Tech Makes Deserts Bloom

Retrieved on: 
Tuesday, February 13, 2024

KFAR VITKIN, Israel, Feb. 13, 2024 /PRNewswire/ -- Extreme weather events—heatwaves, droughts, extreme cold snaps—pose significant threats to agriculture, contributing to the phenomenon of desertification. Globally, fertile lands are increasingly being degraded, losing the ability to sustain life and grow food. AgriTech start-up SaliCrop, Ltd., has pioneered a breakthrough seed treatment to transform arid terrain into flourishing landscapes to growing food.

Key Points: 
  • AgriTech start-up SaliCrop, Ltd., has pioneered a breakthrough seed treatment to transform arid terrain into flourishing landscapes to growing food.
  • SaliCrop's proprietary seed enhancement technology is the brainchild of Ṛcā Godbole, Ph.D., co-founder and CSO of SaliCrop.
  • SaliCrop's has developed  hundreds of seed enhancement protocols designed to improve plant resilience to the impacts of climate change by intentionally exposing the seeds to controlled abiotic stressors.
  • "Our climate-smart seed enhancement technology has empowered tomatoes to better withstand extreme climate events," adds Devir.

Enigma Biomedical - USA Announces Appointment of Hartmuth Kolb, PhD as Chief Scientific Officer

Retrieved on: 
Tuesday, February 13, 2024

Enigma Biomedical USA (EB) today announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer (CSO).

Key Points: 
  • Enigma Biomedical USA (EB) today announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer (CSO).
  • Dr. Kolb’s passion for innovation and scientific rigor has driven his extensive career and broad recognition.
  • He will join Enigma at the beginning of March, 2024.
  • In his 10 year tenure at Johnson & Johnson Innovative Medicine, he served as the Vice President, Neuroscience Biomarkers and Global Head of Imaging.

Meliora Therapeutics Establishes Leadership Team with Key Promotion and New Addition

Retrieved on: 
Monday, February 12, 2024

“These leadership updates mark the beginning of a new phase for Meliora.

Key Points: 
  • “These leadership updates mark the beginning of a new phase for Meliora.
  • We are also excited to welcome Anand, whose experience in cancer biology will be critical in advancing the company’s mission,” said David Li, co-founder and CEO of Meliora Therapeutics.
  • Dr. Claudio Chuaqui’s promotion to CSO comes as Meliora rapidly progresses multiple projects in its internal pipeline under his leadership and expertise.
  • Meliora Therapeutics is discovering and developing small molecule oncology therapies for high value cancer targets with its proprietary machine learning powered platform, AnchorOmics.

Bugcrowd Secures $102 Million in Strategic Growth Funding to Scale AI-Powered Crowdsourced Security Platform

Retrieved on: 
Monday, February 12, 2024

SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- Bugcrowd has secured $102 million in strategic growth financing to scale its AI-powered crowdsourced security platform offerings globally. Led by General Catalyst, with participation from longtime existing investors Rally Ventures and Costanoa Ventures, this funding round underscores investor confidence in the company's leadership position in the crowdsourced security market. The additional capital enables Bugcrowd to accelerate growth across EMEA, APAC, and the United States, fund continued innovation into the Bugcrowd Platform, and leverage opportunities for strategic M&A, providing added value to clients, partners, and the hacker community.

Key Points: 
  • SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- Bugcrowd has secured $102 million in strategic growth financing to scale its AI-powered crowdsourced security platform offerings globally.
  • The additional capital enables Bugcrowd to accelerate growth across EMEA, APAC, and the United States, fund continued innovation into the Bugcrowd Platform, and leverage opportunities for strategic M&A, providing added value to clients, partners, and the hacker community.
  • Bugcrowd's proactive approach to cybersecurity involves leveraging a crowdsourced AI-powered platform to identify and remediate security vulnerabilities before bad actors can exploit them.
  • To learn more about how the Bugcrowd Platform can equip your organization to protect itself from cyber risk, access link here .

Bugcrowd Secures $102 Million in Strategic Growth Funding to Scale AI-Powered Crowdsourced Security Platform

Retrieved on: 
Monday, February 12, 2024

SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- Bugcrowd has secured $102 million in strategic growth financing to scale its AI-powered crowdsourced security platform offerings globally. Led by General Catalyst, with participation from longtime existing investors Rally Ventures and Costanoa Ventures, this funding round underscores investor confidence in the company's leadership position in the crowdsourced security market. The additional capital enables Bugcrowd to accelerate growth across EMEA, APAC, and the United States, fund continued innovation into the Bugcrowd Platform, and leverage opportunities for strategic M&A, providing added value to clients, partners, and the hacker community.

Key Points: 
  • SAN FRANCISCO, Feb. 12, 2024 /PRNewswire/ -- Bugcrowd has secured $102 million in strategic growth financing to scale its AI-powered crowdsourced security platform offerings globally.
  • The additional capital enables Bugcrowd to accelerate growth across EMEA, APAC, and the United States, fund continued innovation into the Bugcrowd Platform, and leverage opportunities for strategic M&A, providing added value to clients, partners, and the hacker community.
  • Bugcrowd's proactive approach to cybersecurity involves leveraging a crowdsourced AI-powered platform to identify and remediate security vulnerabilities before bad actors can exploit them.
  • To learn more about how the Bugcrowd Platform can equip your organization to protect itself from cyber risk, access link here .

GMGI Appoints Dr. Andrew Gardner as Inaugural Chief Scientific Officer

Retrieved on: 
Wednesday, February 7, 2024

GLOUCESTER, Mass., Feb. 7, 2024 /PRNewswire/ -- Gloucester Marine Genomics Institute (GMGI), a 501c3 non-profit addressing critical challenges facing our oceans, human health, and the environment through innovative scientific research and education, announced the appointment of Dr. Andrew Gardner as the organization's inaugural Chief Scientific Officer (CSO).

Key Points: 
  • GLOUCESTER, Mass., Feb. 7, 2024 /PRNewswire/ -- Gloucester Marine Genomics Institute (GMGI), a 501c3 non-profit addressing critical challenges facing our oceans, human health, and the environment through innovative scientific research and education, announced the appointment of Dr. Andrew Gardner as the organization's inaugural Chief Scientific Officer (CSO).
  • Dr. Gardner brings an impressive track record of discovery, innovation and team leadership after 28 years at New England Biolabs, in Ipswich, MA, most recently as Scientific Director of Molecular Enzymology.
  • As CSO, Dr. Gardner will drive the scientific strategy for GMGI's next phase of growth.
  • "We are delighted to have Dr. Gardner join the GMGI team in this capacity.